TickerFactsScreenerDevelopers

Neurogene Inc. (NGNE) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $6.4K2013: $11.0K2014: $114.0K2015: $26.0K2016: $713.0K2017: $494.0K2018: $49.0K2019: $879.0K2020: $2.22M2021: $3.26M2022: $2.23M2023: $321.0K2024: $808.0K2025: $1.18M$1.18M
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$1.18M+46.4%
2024$808.0K+151.7%
2023$321.0K-85.6%
2022$2.23M-31.7%
2021$3.26M+47.0%
2020$2.22M+152.4%
2019$879.0K+1693.9%
2018$49.0K-90.1%
2017$494.0K-30.7%
2016$713.0K+2642.3%
2015$26.0K-77.2%
2014$114.0K+936.4%
2013$11.0K+70.6%
2012$6.4K—